Jul 25 2024
Multiple sclerosis is a chronic progressive autoimmune disease that leads to severe disability over time through a complex pattern of progression, recovery, and relapse. Its global prevalence has increased by more than 30% over the last decade. Yet there are few tools that can predict the progression of MS to help clinicians and patients make life planning and treatment decision-making.
In the new study, De Brouwer and colleagues used data on 15,240 adults with at least three years of MS history who were being treated at 146 MS centers in 40 countries. Data on two years of each patient's disease progression was used to train state-of-the-art machine learning models to predict the probability of disease progression over the subsequent months and years.
The authors conclude that the models developed in the study have the potential to greatly enhance planning for individuals with MS and could be evaluated in a clinical impact study. Related StoriesDe Brouwer adds: "Using the clinical history of more than 15,000 people with multiple sclerosis, we trained a machine learning model capable of reliably predicting the probability of disability progression in the next two years. The model only uses routinely collected clinical variables, which makes it widely applicable.
Ai Ai Latest News, Ai Ai Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: NewsMedical - 🏆 19. / 71 Read more »